Loading...
Images of Olivier Deas
(1 - 1 from 1 )1
0
0
Network Profiles
LinkedIn: Olivier DEAS - France | LinkedIn
Voir le profil professionnel de Olivier DEAS (France) sur LinkedIn. Olivier DEAS IR at INSERM Location Paris Area, France Industry Biotechnology Inscrivez-vous sur
Business Profiles
Researchgate: Olivier Deas
Évry, France
Olivier DEAS, XenTech - France | Viadeo
fr.viadeo.com
XenTech is primarily a contract research organization (CRO) specializing in preclinical evaluation of novel anti-tumor agents. Our business model is open and flexible ...
ResearchGate
www.researchgate.net
ResearchGate is a network dedicated to science and research. Connect, collaborate and discover scientific publications, jobs and conferences. All for free.
Chapel Alain | IRSN | ZoomInfo.com
www.zoominfo.com
Alain Chapel*, Olivier Deas, Morad Bensidhoum, Sabine François, Moubarak Mouiseddine, Pascal Poncet, Antoine Dürrbach, Jocelyne Aigueperse, Patrick ...
Education
Olivier DEAS, 47 ans (LES ULIS, ORSAY) - Copains d'avant
copainsdavant.linternaute.com
DEAS Olivier : Olivier DEAS, né en 1969 et habite LES ULIS. Aux dernières nouvelles il était à Université De Paris Sud Xi à ORSAY entre 1992 et 1999. Il a...
Books & Literature
JoVE | Peer Reviewed Scientific Video Journal - Methods and Protocols
www.jove.com
JoVE publishes peer-reviewed scientific video protocols to accelerate biological, medical, chemical and physical research. Watch our scientific video articles.
FranceNcbiV1, Main, Exploration, indexHead, Author.i
ticri.univ-lorraine.fr
00D018 (2004), Alain Chapel (France) ; Olivier Deas ; Morad Bensidhoum ; Sabine François ; Moubarak Mouiseddine ; Pascal Poncet ; Antoine Dürrbach ...
Related Documents
CiteSeerX — Genetic Vaccines and Therapy BioMed Central
citeseerx.ist.psu.edu
BibTeX @MISC{Chapel04geneticvaccines, author = {Alain Chapel and Olivier Deas and Morad Bensidhoum and Sabine François and Moubarak Mouiseddine and Pascal …
Abstract 204: Understanding breast cancer resistance to chemotherapy:...
cancerres.aacrjournals.org
Olivier Deas 3, Sophie Banis 3, Enora L. Ven 3, Andreas Bosio 1, Olaf Hardt 1, Stefano Cairo 3, and Jean-Gabriel Judde 3 ...
Noms extraits de theses.fr - Data.gouv.fr
www.data.gouv.fr
... SANDRINE LE MEE Séverine Le Loarne Inès Bouden Marie Vian OLIVIER DEAS Sebastien Schifres Gerard Delille EVELYNE EMERY Daniela Dragah David ...
MOLECULAR CONJUGATES
pfjspark.maru.net
Highly Efficient Antibody-targeted Gene Transfer Using Fusogenic Influenzae Peptide and Histone H1 asa DNA Carrier Antoine Durrbach, Olivier Deas, Eric Angevin, Anna Senik, Egbert ...
Scientific Publications
NOTCH1 Nuclear Interactome Reveals Key Regulators of Its ...
www.sciencedirect.com
Ahmad Yatim,,, , ,; Clarisse Benne,; Bijan Sobhian,; Sabine Laurent-Chabalier,; Olivier Deas,; Jean-Gabriel Judde,; Jean-Daniel Lelievre,,,; Yves Levy,,, ...
In vivogene targeting of IL-3 into immature hematopoietic cells...
gvt-journal.biomedcentral.com
... Olivier Deas 3 4, Morad Bensidhoum 2, Sabine François 1 2, Moubarak Mouiseddine 1 2, Pascal Poncet 4, Antoine Dürrbach 3, Jocelyne Aigueperse 1, Patrick ...
Publications
Publications Authored by Francois Hirsch
www.pubfacts.com
Olivier Déas, Eric Angevin, Claire Cherbonnier, Anna Senik, Bernard Charpentier ... Alain Chapel, Olivier Deas, Morad Bensidhoum, Sabine François, Moubarak ...
Antibodies, a Potent Tool to Target Genes into Designated Cells and...
link.springer.com
Francois Hirsch Affiliated with GDR 2352 “immunotargeting of tumors”, Inserm unit 542, Paris-Sud University, Olivier Deas Affiliated with GDR 2352 ...
Olivier Deas's Research | CureHunter
www.curehunter.com
Olivier Deas Selected Research. Olivier Deas Research Topics. Disease. 1, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 11/2012 ...
theses.fr – OLIVIER DEAS , Mort cellulaire caspase-independante...
www.theses.fr
La mort cellulaire programmee, ou apoptose, induite dans les lymphocytes t matures est un evenement clef pour le maintien de la tolerance peripherique et l ...
Miscellaneous
Olivier DEAS | LinkedIn
www.linkedin.com
View Olivier DEAS's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Olivier DEAS discover inside ...
Olivier DEAS | LinkedIn
www.linkedin.com
View Olivier DEAS' professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Olivier DEAS discover inside ...
Olivier Deas Ph.D.: Executive Profile & Biography - Bloomberg
www.bloomberg.com
Mr. Olivier Deas, Ph.D. serves as Department Head of Cell Biology - R&D at XenTech SAS. Mr. Deas serves as Manager of XenTechs cell biology department. He has...
Abstract C115: Response to trastuzumab of HER2-overexpressing breast...
mct.aacrjournals.org
Citation Format: Jean-Gabriel Judde, Olivier Deas, Myriam Lassalle, Victorine Boissay, Anais Delaitre, Delphine Nicolle, Stefano Cairo, ...
Deas - Names Encyclopedia
www.namespedia.com
Olivier Deas (1) Christine Deas (1) Claudine Deas (1) Anthony Deas (1) Yvonne Deas (1) Christian Deas (1) Odette Deas (1) Sheila Deas (1) Shiona Deas (1) Marcelle ...
XenTech SAS: CEO and Executives - Bloomberg
www.bloomberg.com
Get to know XenTech SAS CEO & other corporate executives. Learn about the Board of Directors, Executive Committees and CEO compensation in this industry.
Abstract P5-06-04: The PARP inhibitor niraparib demonstrated activity...
cancerres.aacrjournals.org
Citation Format: Yan Wang, Stefano Cairo, Olivier Deas, Anne-Renee Hartman, Joshua Jones, Alexander Gutin, Jerry Lanchbury, Zaina Sangale ...
XenTech SAS: Private Company Information - Bloomberg
www.bloomberg.com
XenTech SAS company research & investing information. Find executives and the latest company news.
NOTCH1 Nuclear Interactome Reveals Key Regulators of Its...
www.infona.pl
autor. Sabine Laurent-Chabalier. Laboratoire de Virologie Moléculaire CNRS-UPR1142, Institut de Génétique Humaine, Montpellier, France. autor. Olivier Deas.
Xentech | In vivo pharmacology, tumor xenograft models and...
www.xentech.eu
Young motivated engineers and technicians with strong background in in vivo pharmacology, tumor xenograft models and molecular and cell biology.
CNRS - Sciences biologiques - Parutions
www.cnrs.fr
... Clarisse Benne, Bijan Sobhian, Sabine Laurent-Chabalier, Olivier Deas, Jean- Gabriel Judde, Jean-Daniel Lelievre, Yves Levy, Monsef Benkirane, Molecular ...
Papers in the journal Genetic Vaccines and Therapy (Page 5) | Read by...
www.readbyqxmd.com
Alain Chapel, Olivier Deas, Morad Bensidhoum, Sabine François, Moubarak Mouiseddine, Pascal Poncet, Antoine Dürrbach, Jocelyne Aigueperse, Patrick ...
Olivier DEAS | LinkedIn
www.linkedin.com
View Olivier DEAS's professional profile on LinkedIn. Experience: IR, INSERM U542.
In vivo gene targeting of IL-3 into immature hematopoietic cells...
europepmc.org
FULL TEXT Abstract: BACKGROUND: Targeted gene transfection remains a crucial issue to permit the real development of genetic therapy. As such, in vivo...
Targa Thérapies développe des thérapies géniques anticancers
www.industrie-techno.com
- Créateurs : Olivier Deas, François Hirsch, Antoine Dürrbach, François Deneux et Patrick Rousseau. - Contacts : odeas@infobiogen.fr , targatherapies@aol.com, rouspat1@oal.com
Related search requests for Olivier Deas
| Pascal Poncet Bijan Sobhian Jean-Gabriel Judde | Jean-Daniel Lelievre Yves Levy Sabine François | Alain Chapel |
People Forename "Olivier" (18362) Name "Deas" (490) |
sorted by relevance / date